Combination chemotherapy with irinotecan and gemcitabine for taxane/platinum-resistant/refractory ovarian and primary peritoneal cancer: a multicenter phase I/II trial (GOGO-Ov 6)

Autor: Kiyoshi Yoshino, Takeshi Yokoi, Ruriko Nakae, Tadashi Kimura, Masami Fujita, Masahiko Takemura, Shoji Kamiura, Tateki Tsutsui, Takuji Tomimatsu, Kazushige Adachi, Eiji Kobayashi, Seiji Mabuchi, Kenjiro Sawada, Yasuhiko Shiki, Yutaka Ueda, Kae Hashimoto, A. Wakimoto, Takamichi Nishizaki, Yuki Kanda
Rok vydání: 2017
Předmět:
Zdroj: Cancer Chemotherapy and Pharmacology. 80:1239-1247
ISSN: 1432-0843
0344-5704
Popis: To develop a new therapeutic strategy for taxane/platinum-resistant/refractory ovarian and primary peritoneal cancers, we evaluated the feasibility and efficacy of irinotecan and gemcitabine combination chemotherapy.Patients with taxane/platinum-resistant/refractory cancer received escalating doses of irinotecan and gemcitabine (level 1: 80 and 800 mg/mA total of 35 patients were enrolled. The recommended dose was defined as 100 mg/mCombination chemotherapy with irinotecan and gemcitabine represents a safe and effective treatment combination for taxane/platinum-resistant/refractory ovarian and primary peritoneal cancers.
Databáze: OpenAIRE